FoLix (Fractional Laser for Hair)
World's first FDA-cleared fractional laser for hair loss treatment
About This Treatment
FoLix by Lumenis is the world's first and only FDA-cleared fractional laser specifically for hair loss treatment. Non-ablative 1064nm Nd:YAG creates microscopic thermal zones (MTZs) to activate natural follicular healing.
Winner of 2025 MedTech Breakthrough "Best New Dermatology Technology Solution" and NewBeauty "Best Laser Treatment for Hair Loss." A new option for patients resistant to medications or as PRP adjunct.
Mechanism of Action
1064nm non-ablative fractional laser creates MTZs on the scalp, stimulating stem cells in the follicular bulge region and activating Wnt signaling pathway. Inflammatory cascade releases growth factors (VEGF, FGF, IGF-1), reversing follicular miniaturization and transitioning resting follicles to active growth phase.
Indications
Expected Results
Hair density increase confirmed after 4-6 sessions. Peak results 3-6 months after final treatment. Most effective for early-to-mid stage hair loss. Enhanced with medication and PRP combination. Maintenance 2-3x/year recommended.
Clinical Evidence
Risks & Side Effects
Mild discomfort during treatment (manageable with topical anesthesia). Transient scalp redness (hours). Minimal downtime. Limited efficacy for advanced hair loss with complete follicle loss.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition